WebJan 17, 2024 · The answer to both questions is yes, based in part on updated results from the phase 2 GRIFFIN trial (NCT02874742), says Jacob Laubach, MD, MPP, senior … Web2 days ago · Rebecca Silbermann, MD, MMS, associate professor of medicine at the Division of Hematology/Medical Oncology at Oregon Health & Science University, discusses the relevance of patient-reported outcomes from the phase 2 GRIFFIN study (NCT02874742) and the importance of individualizing treatment for patients with multiple …
ASH 2024 update from the GRIFFIN trial of dara-RVd in newly …
WebDec 7, 2024 · About the GRIFFIN Study 3 The Phase 2 GRIFFIN (NCT02874742) study has enrolled and treated more than 200 adults ages 18-70 years with NDMM and who are eligible for high-dose therapy/autologous ... WebNov 5, 2024 · Introduction: DARA, a human IgGκ monoclonal antibody targeting CD38, is approved as monotherapy and in combination with standard-of-care regimens for relapsed/refractory multiple myeloma and … bolt charged bramble location
DC2 - US English
WebNov 5, 2024 · The phase 2 randomized GRIFFIN study (NCT02874742) evaluates frontline DARA in combination with lenalidomide, bortezomib, and dexamethasone (D-RVd) in transplant-eligible NDMM. In the primary analysis, ... In GRIFFIN, 93.7% of D-RVd pts and 98.8% of RVd pts reached the minimum institutional CD34 + threshold to perform a … WebSep 15, 2024 · In the phase II GRIFFIN study (NCT02874742), investigators randomized patients with transplant-eligible multiple myeloma 1:1 to receive VRd with or without daratumumab. Patients received 4 ... WebAug 27, 2024 · Zestimate® Home Value: $217,000. 102 Griffin Dr, Greenville, SC is a single family home that contains 1,029 sq ft. It contains 2 bedrooms and 1 bathroom. The Zestimate for this house is $267,600, … gmail view all attachments